Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
ViewRay, Inc. logo — Conquer cancer by re-envisioning radiation therapy.

ViewRay, Inc.

Conquer cancer by re-envisioning radiation therapy.

Founded 2004 United States United States 76 employees Post Ipo Debt Total: $462.49M Biotechnology, Health Care +2

General Information

Company Name ViewRay, Inc.
Founded Year 2004
Location United States United States +4
Founders / Decision Makers
Team member Team member Team member
Employees 76
Industries Biotechnology, Health Care, Manufacturing +1
Funding Stage Post Ipo Debt
Social

Get notified when ViewRay, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About ViewRay, Inc.

ViewRay, Inc. is a pioneering company, founded in 2004, with a mission to revolutionize cancer treatment. Its flagship product, the MRIdian® MRI-guided adaptive radiotherapy system, is disrupting the field with its innovative approach. The system's real-time imaging capability, precise dose shaping, and automated beam gating set it apart from existing radiation therapy technologies. With over $125.00MPost-IPO Debt investment from MidCap Financial and Silicon Valley Bank in November 2022, ViewRay, Inc. is poised for further growth. The company's dedication to advancements in biotechnology, healthcare, and manufacturing make it an attractive prospect for investors looking to make a meaningful impact in the fight against cancer. ViewRay, Inc.'s commitment to diversity and its focus on improving patient outcomes position it as an innovative and purpose-driven player in the industry. With a track record of treating over 12,500 patients worldwide, ViewRay, Inc. is demonstrating tangible results and offering a compelling opportunity for stakeholders seeking to make a difference in cancer care.

Taxonomy: Radiation Therapy, Cancer Treatment, MRI-guided Adaptive Radiotherapy, Medical Technology, Oncology, MRI Technology, Healthcare Innovation, Clinical Imaging, Cancer Therapy, Precision Medicine, Radiation Oncology, Cancer Care, Tumor Targeting, Patient Outcomes

Funding Rounds & Investors (15)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• - 19 Nov 2021
Post-IPO Equity •••••• 1 •••• •••• 06 Dec 2019
Debt Financing •••••• 1
Investor
01 Jan 2019
Post-IPO Equity •••••• - 26 Feb 2018
Post-IPO Equity •••••• - 25 Oct 2017

View All 15 Funding Rounds

ViewRay, Inc. Alternatives & Competitors

ViewRay, Inc. vs
S C Oncology
S C Oncology

South Carolina Oncology Associates (SCOA) is the only comprehensive cancer treatment center in South...

15 employees
Health Care
ViewRay, Inc. vs
Mevion Medical Systems
Mevion Medical Systems United States

Proton Therapy Has Changed. Right Size. Right Technology. Right Now.

Private Equity
202 employees
Biotechnology, Health Care
Compare ViewRay, Inc. vs Mevion Medical Systems
ViewRay, Inc. vs
Minneapolis Radiation Oncology, P.A.
Minneapolis Radiation Oncology, P.A. United States

The Twin Cities'​ leading provider of radiation treatment for cancer.

97 employees
Health Care, Health and Wellness
Compare ViewRay, Inc. vs Minneapolis Radiation Oncology, P.A.
Also compare with: ViewRay, Inc. vs Leo Cancer Care Leo Cancer Care

FAQ About ViewRay, Inc.

Conquer cancer by re-envisioning radiation therapy.
ViewRay, Inc. was founded in 2004.
ViewRay, Inc. is headquartered in United States.
ViewRay, Inc. operates in the following industries: Biotechnology, Health Care, Manufacturing, Medical Devices.
ViewRay, Inc. has approximately 76 employees.
ViewRay, Inc. has completed 15 funding rounds, raising a total of $462.49M. The latest funding stage is Post Ipo Debt.
Top alternatives and competitors to ViewRay, Inc. include S C Oncology, Mevion Medical Systems, Minneapolis Radiation Oncology, P.A., Leo Cancer Care, IBA Dosimetry. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ViewRay, Inc. and S C Oncology are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors ViewRay, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy